David Ebersman
Co-Founder & CEO
Description:
David is founder and CEO of Lyra Health, a health care technology company focused on behavioral health. Previously, he served as Chief Financial Officer of Facebook, Inc. from 2009 through 2014. Prior to joining Facebook, David worked at Genentech, Inc. for 15 years in various positions, including Executive Vice President and Chief Financial Officer, Senior Vice President, Product Operations, and Vice President, Product Development. David holds an A.B. in International Relations and Economics from Brown University and was selected as a Henry Crown Fellow in 2000.
Summary:
David is founder and CEO of Lyra Health, a health care technology company focused on behavioral health. Previously, he served as Chief Finan...
Number of Registered Investments:1
Contact Details:
- Address: Burlingame, California, United States
- No email is provided
Location:Burlingame, California, United States
Email is Not Provided
Phone Number:Burlingame, California, United States
Updated August 2023. This content was crafted by an associate of Najafi Capital (“Najafi”) and is presented strictly for informational objectives. The details on this page neither advocate for nor dissuade the subscription, acquisition, or sale of any security or offering. The material Najafi evaluates for project owner screening and due diligence stems directly from the project owner presenting the investment opportunity. While Najafi perceives the information to have been sourced from trustworthy channels, there is no absolute assurance, warranty, or representation concerning its authenticity. Najafi renounces any liability regarding content provided by the project owner, inclusive of the data utilized to fulfill elements outlined on this page. Najafi is not accountable for the precision, legality, or the affirmation of subsequent details shared by the project owner.
Prospective investors are urged to perform their individual due diligence and authenticate the provided data. Investing inherently encompasses risks, inclusive of the potential loss of capital invested. All investors are recommended to ponder over these aspects in tandem with a chosen professional consultant to ascertain the suitability of an investment.